RELIEF Study: Real-world Evaluation of LUTS Interventions & Patient

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04807296` - Thulium Fiber Laser Enucleation of the Prostate (TFLEP) vs HoLEP With Moses Technology (m-HoLEP)	N/A
Recruiting	`NCT05574244` - Comparison of Functional Outcomes of Ejaculation-preserving Partial Trans Urethral Resection of the Prostate With Complete Trans Urethral Resection of the Prostate for Benign Prostatic Obstruction	N/A
Recruiting	`NCT04288427` - 5-Alpha Reductase 2 as a Marker of Resistance to 5ARI Therapy	N/A
Not yet recruiting	`NCT04245566` - Prostatic Artery Embolization vs. Pharmacotherapy for LUTS/BPH	Phase 3
Completed	`NCT03246880` - Clinical Trial To Evaluate the Efficacy and Safety of CKD-397 in Benign Prostatic Hyperplasia Patients	Phase 3
Withdrawn	`NCT01967251` - Efficacy, Safety and Dose-response of Udenafil in Patients With Benign Prostatic Hyperplasia and Erectile Dysfunction	Phase 2
Completed	`NCT02509975` - Safety and Efficacy of OCL 503 in Prostate Artery Embolization	N/A
Completed	`NCT02283684` - GreenLight Laser Photoselective Vaporization of the Prostate vs Bipolar Transurethral Vaporization of the Prostate; RCT	Phase 4
Completed	`NCT02206243` - Embozene® Microspheres for Prostatic Arterial Embolization in Patients With Symptomatic Benign Prostatic Hyperplasia
Completed	`NCT01454349` - Study of PRX302 for Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia (BPH)	Phase 1/Phase 2
Completed	`NCT01438775` - Phase 3 Evaluation of Re-Injection of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH)	Phase 3
Completed	`NCT01139762` - A Study of Tadalafil Use With Finasteride in Men With Enlarged Prostates and Urinary Symptoms	Phase 3
Completed	`NCT01152190` - A Study in Benign Prostatic Hyperplasia	Phase 3
Active, not recruiting	`NCT00400894` - Annexin A3 (ANXA3) as Protein-Based Marker for Non-Invasive Molecular Diagnostics of Prostate Carcinoma	N/A
Completed	`NCT00701779` - Dutasteride and Flex Dose of Tamsulosin on as Needed Basis, to Treat Benign Prostatic Hyperplasia	Phase 4
Unknown status	`NCT00381108` - Study of the Effects of Pomegranate Tablets on Enlarged Prostates	Phase 1
Completed	`NCT00224133` - The Evaluation of the Safety of a New Drug for Benign Prostatic Hyperplasia Used for 9 Months	Phase 3
Terminated	`NCT02962674` - To Evaluate the Safety and Performance of the ProstaCare Water Electrolysis System in Relieving Symptoms of BPH.	N/A
Active, not recruiting	`NCT05415748` - Deprescribing Tamsulosin in Older Men	Phase 4
Recruiting	`NCT04853914` - Evaluation of the Safety of the Treatment of Benign Prostatic Hyperplasia by High Intensity Focused Ultrasound.	N/A

NCT number	NCT05784558
Study type	Observational
Source	NeoTract, Inc.
Contact
Status	Not yet recruiting
Phase
Start date	April 3, 2023
Completion date	December 31, 2030

RELIEF Study: Real-world Evaluation of LUTS Interventions and Patient Experience During Follow-up — RELIEF

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms